Antibody–drug conjugates for bladder sparing: lessons from SURE-02 trial

The Lancet Oncology 2026

View at publisher
Authors: Kriti Mittal, Monika Joshi
DOI: 10.1016/s1470-2045(26)00073-2
Cited by: 0
References: 8

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Urinary Tract Infections Management

Publication details

Journal / source
The Lancet Oncology
Volume
27
Issue
4
Pages
397–399
Publication date
27 February 2026
Language
EN